BALT USA, LLC The Optima Coil System consists of an implantable embolization coil comprised of a platinum-tungsten alloy attached to a proximal stainless steel hypo-tube and distal body coil delivery pusher with a radiopaque distal positioning marker and proximal fluorosafe marker. The Optima Coil delivery pusher is 185cm in length. it is designed for use with the XCEL Detachment Controller. The XCEL Detachment Controller comes pre-loaded with batteries and is a sterile, handheld, single-patient-use device Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
The Optima Coil System consists of an implantable embolization coil comprised of a platinum-tungsten alloy attached to a proximal stainless steel hypo-tube and distal body coil delivery pusher with a radiopaque distal positioning marker and proximal fluorosafe marker. The Optima Coil delivery pusher is 185cm in length. it is designed for use with the XCEL Detachment Controller. The XCEL Detachment Controller comes pre-loaded with batteries and is a sterile, handheld, single-patient-use device
Brand
BALT USA, LLC
Lot Codes / Batch Numbers
Not specified in FDA notice. Check official source for details.
Products Sold
Model/REF: OPTI0204CSF10 Lot Number: F210500134 UDI Code: 00818053026010 Model/REF: OPTI0407CSF10 Lot Number: F210500135 UDI Code: 00818053026096
BALT USA, LLC is recalling The Optima Coil System consists of an implantable embolization coil comprised of a platinum-tungsten due to Due to Label/Pouch mix-up. Pouches incorrectly labeled. Incorrect shelf carton label or pouch label due to inadequate manufacturing line clearance. A. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Due to Label/Pouch mix-up. Pouches incorrectly labeled. Incorrect shelf carton label or pouch label due to inadequate manufacturing line clearance. As a result of this labeling mix-up, there is the possibility of inadvertently selecting the incorrect coil size for the procedure potentially causing some harms like vessel damage, an inability to treat with said device and potential rupture of the aneurysm.
Recommended Action
Per FDA guidance
On 01/04/2022, the firm sent an "URGENT FIELD SAFETY NOTICE (FSN)/PRODUCT RECALL" letter via email to customers notifying them of the labeling mix-up which presents a high risk to patient safety and product performance, with the possibility that the user could inadvertently select the wrong size coil for a procedure. Customer/Distributors are instruction to: -Inform their customers about the notice; -Identify and locate the affected products -Collect and put in quarantine the affected products and return them to the Recalling Firm through the Return Material Authorization procedure by contacting the Recalling Firm's Customer Service Department. -Inform the Recalling Firm about the status of every unit of the affected products. -Fulfill the Notice of receipt then return to the Recall Firm via the indicated contact For Hospital Staff: -Within their hospital, inform all Safety Officers, Pharmacists, Head of Neuroradiology and the Neuroradiology Department Staff as well as any other person if deemed necessary. -Identify and locate all affected products and cease or stop using. -Collect and put in quarantine all affected products and return them to their local distributor as per its return procedure; -Inform their local distributor and the Recalling Firm about the status of every unit of affected product. -Contact their local distributor or the Recalling Firm for any additional informaiton. For questions or assistance, contact Quality Department at: email QA@balt-usa.com address: 29 Parker Suite 100, Irvine CA 92618, USA Telephone number: 949-788-1443 or Fax 949-788-1444
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026